PECAM1 and neoplasm: In addition, the suppressive effect of SIS3 on cancer progression was also associated with inhibition of angiogenesis (CD31 and VEGF) and tumour-invasive and metastatic activities, including the expression of MMP-2, MMP-9, MMP-13 and CXCR4.